UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010475
Receipt number R000012241
Scientific Title Determination of the effect of topical glucorticosteroid on the barrier function of human nasal mucosa
Date of disclosure of the study information 2013/04/12
Last modified on 2017/04/15 11:33:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Determination of the effect of topical glucorticosteroid on the barrier function of human nasal mucosa

Acronym

Effects of topical glucorticosteroid on the human nasal barrier

Scientific Title

Determination of the effect of topical glucorticosteroid on the barrier function of human nasal mucosa

Scientific Title:Acronym

Effects of topical glucorticosteroid on the human nasal barrier

Region

Japan


Condition

Condition

allergic rhinitis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To detect the effect of topical glucocorticoid, pre and post nasal provocation on nasal mucosal barrier

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

nasal transepithelial water loss, nasal potential differences

Key secondary outcomes

clinical symptoms


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

fluticasone furoate

Interventions/Control_2

fluticasone furoate placebo

Interventions/Control_3

mometasone furoate

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Japanese cedar poliinosis

Key exclusion criteria

allergic rhinitis with active inflammation

Target sample size

1


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name masato miwa

Organization

Juntendo Universiry

Division name

Otorhinolaryngology

Zip code


Address

3-1-3 Hongo Bunkyo Tokyo

TEL

03-5802-1229

Email

mmiwa@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name masato miwa

Organization

Juntendo Universiry

Division name

Otorhinolaryngology

Zip code


Address

3-1-3 Hongo Bunkyo Tokyo

TEL

03-5802-1229

Homepage URL


Email

mmiwa@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Juntendo University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂医院(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 03 Month 22 Day

Date of IRB


Anticipated trial start date

2013 Year 03 Month 22 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 01 Month 31 Day

Date trial data considered complete

2014 Year 02 Month 28 Day

Date analysis concluded

2014 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 04 Month 12 Day

Last modified on

2017 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012241


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name